Compare
Microbot Medical Inc. vs PRO DEX Inc vs SS Innovations International, Inc. vs Xtant Medical Holdings, Inc.
| Latest fiscal year | Microbot Medical Inc. MBOTRevenue covers only part of its income (partial revenue) | PRO DEX Inc PDEX | SS Innovations International, Inc. SSII | Xtant Medical Holdings, Inc. XTNT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-06-30 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $77.55M | $42.48M | $133.93M |
| Revenue growth (YoY) | n/a | +16.5% | +105.7% | +14.2% |
| Gross margin | n/a | 31.4% | 46.0% | 62.9% |
| Operating margin | n/a | 16.8% | -19.3% | 5.4% |
| Net margin | n/a | 17.6% | -28.5% | 3.7% |
| Net income | -$13.14M | $13.66M | -$12.13M | $4.97M |
| EPS (Diluted) | -$0.29 | $4.12 | -$0.06 | $0.03 |
| Operating cash flow | -$13.05M | $7.24M | -$18.54M | $12.55M |
| Free cash flow | -$13.11M | $6.76M | -$22.20M | $10.16M |
| Cash & equivalents | $3.91M | $8.19M | $3.21M | $17.05M |
| Total assets | $81.54M | $74.51M | $74.23M | $94.14M |
| Total liabilities | $3.99M | $26.88M | $36.01M | $43.19M |
| Shareholders' equity | $77.55M | $47.63M | $38.22M | $50.95M |
| Return on year-end equity | -16.9% | 28.7% | -31.7% | 9.8% |
| Shares outstanding | 67.16M | 3.19M | 194.17M | 140.04M |
Revenue, most recent five fiscal years
| Fiscal year | Microbot Medical Inc. | PRO DEX Inc | SS Innovations International, Inc. | Xtant Medical Holdings, Inc. |
|---|---|---|---|---|
| Latest | n/a | $77.55M Ended 2026-06-30 | $42.48M Ended 2025-12-31 | $133.93M Ended 2025-12-31 |
| 1 year earlier | n/a | $66.59M Ended 2025-06-30 | $20.65M Ended 2024-12-31 | $117.27M Ended 2024-12-31 |
| 2 years earlier | n/a | $53.84M Ended 2024-06-30 | $5.88M Ended 2023-12-31 | $91.30M Ended 2023-12-31 |
| 3 years earlier | n/a | $46.09M Ended 2023-06-30 | $1.44M Ended 2022-12-31 | $57.97M Ended 2022-12-31 |
| 4 years earlier | n/a | $42.04M Ended 2022-06-30 | n/a | $55.26M Ended 2021-12-31 |